Understanding and Treating Systemic Metastasis


MetaStat, Inc. (OTCBB: MTST) is a life sciences company that develops and commercializes best-in-class diagnostic products and novel therapeutics for the early and reliable prediction and treatment of systemic metastasis - cancer that spreads from a primary tumor through the bloodstream to other areas of the body. MetaStat is focused on breast, prostate, lung and colorectal cancers, where systemic metastasis is responsible for ~90% of all deaths. As such, we believe that more effective treatment of metastatic disease and/or the prevention of systemic metastasis is needed to improve patient outcomes. 

Scientific Publications

Tumor microenvironment of metastasis and risk of distant metastasis of breast cancer

2014 - Journal of the National Cancer Institute - Rohan et al.